Immunohistochemistry is widely used for the evaluation of BC markers such as the estrogen receptor (ER), the progesterone receptor, the human epidermal growth factor receptor 2, and the proliferation marker protein Ki-67, thereby facilitating the diagnosis and molecular subtyping of BC and guiding a more personalized treatment. This evidence concerns the gene ESR1 and breast cancer.